A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis

Respiratory Medicine

Volumn 107, Issue 6, 2013, Pages 890-896

  Mira Avendano, Isabel C ^a   Parambil, Joseph G ^a   Yadav, Ruchi ^a   Arrossi, Valeria ^a   Xu, Meng ^a   Chapman, Jeffrey T ^b   Culver, Daniel A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HEART AND VASCULAR INSTITUTE   (United Arab Emirates)

Author keywords

Dermatomyositis; Immunosupressive agents; Interstitial lung disease; Polymyositis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; DERMATOMYOSITIS; DYSPNEA; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; POLYMYOSITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; DYSPNEA; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POLYMYOSITIS; PREDNISONE; PULMONARY DIFFUSING CAPACITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84877578326     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.02.015     Document Type: Article

References (37)

1. W. Travis, T. Colby, M. Koss, M. Rosado-de Christenson, N.L. Muller, and T.E. King Non-neoplastic disorders of the lower respiratory tract Armed Forces Institute of Pathology First series. Fascicle 2. 2002 291 310
2. G.R. Connors, L. Christopher-Stine, C.V. Oddis, and S.K. Danoff Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138 2010 1464 1474
3. D.P. Tashkin, R. Elashoff, P.J. Clements, J. Goldin, M.D. Roth, D.E. Furst For the Scleroderma Lung Study Group Cyclophosphamide versus placebo in scleroderma lung disease New England Journal of Medicine 354 25 2006 2655 2666
4. R.K. Hoyles, R.W. Ellis, J. Wellsbury, B. Lees, P. Newlands, and N.S.L. Goh A multicenter, prospective, randomized double blind placebo-controlled trial of corticosteroids and intravenous cyclophophamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma Arthritis & Rheumatism 54 12 2006 3962 3970
5. Akiko Kobayashi, and Hiroshi Okamoto Treatment of interstitial lung diseases associated with connective tissue diseases Expert Review of Clinical Pharmacology 5 2 2012 219
6. D.M. Walker, and J. Pope Treatment of systemic sclerosis complications: what to use when first line treatment fails -a consensus of systemic sclerosis experts Seminars Arthritis & Rheumatism 42 1 2012 42 55
7. F.W. Miller, L.G. Rider, P.H. Plotz, D.A. Isenberg, and C.V. Oddis Diagnostic criteria for polymiositis and dermatomyosits The Lancet 362 2003 9397
8. N.S. Goh, S.R. Desai, S. Veeraghavan, D.M. Hansell, S.J. Copley, and T.M. Maher Interstitial lung disease in scleroderma: a simple staging system American Journal of Respiratory Critical Care Medicine 177 2008 1248 1254
9. J.L. Hankinson, J.R. Odencrantz, and K.B. Fedan Spirometric reference values from a sample of the general US population (NHANES III) American Journal of Respiratory Critical Care Medicine 159 1 1999 179 187
10. M. Fathi, and I.E. Lundberg Interstitial lung disease in polymyositis-dermatomyositis Current Opinion in Rheumatology 17 2005 701 706
11. M. Fathi Pulmonary complications of polymyositis-dermatomyositis Seminars in Respiratory and Critical Care Medicine 28 4 2007 451 458
12. I. Marie, L. Lahace, O. Benveniste, K. Delavigne, D. Adoue, and L. Mouthon Long-term outcome of patients with polymyositis-dermatomyositis and anti-pm-Scl antibody British of Dermatology 162 2010 337 344
13. I. Marie, E. Hachulla, P. Cherin, S. Dominique, P.Y. Hatron, and M.F. Hellot Interstitial lung disease in polymyositis-dermatomyositis Arthritis & Rheumatism 47 6 2002 614 622
14. W.W. Douglas, H.D. Tazelaar, T.E. Hartman, R.B. Hartman, P.A. Decker, E.R. Schroeder, and J.H. Ryu Polymiositis-Dermatomyositis associated interstitial lung disease American Journal Respiratory Critical Care Medicine 164 2001 1182 1185
15. A. Selva-O'Collaghan, M. Labrador-Horrillo, X. Munoz-Gall, X. Martinez-Gomez, and J. Majo-Masferrer PM/DM associated lung disease: analysis of series of 81 patients Lupus 14 2005 534 542
16. A. Schnabel, M. Reuter, J. Biederer, C. Richter, and W.L. Gross Interstitial lung disease in polymyositis-dermatomyositis: clinical course and response to treatment Seminars in Arthritis and Rheumatism 32 2003 273 284
17. S. Hayashi, M. Tanaka, H. Kobayashi, T. Nakazono, T. Satoh, and Y. Fukuno HRCT characterization of ILD in PM/DM The Journal of Rheumatology 35 2008 260 269
18. M. Akira, H. Hara, and M. Sakatani Interstitial lung disease in association with polymyositis-dermatomysitis: long-term follow up CT evaluation in seven patients Radiology 210 2 1999 333 338
19. Y. Yang, J. Fujita, M. Tokuda, S. Bandoh, T. Ishida, and J. Fujit Chronological evaluation of the onset of histologically confirmed interstitial pneumonia associated with polymyositis-dermatomyosits Internal Medicine 41 2002 1135 1141
20. W. Gruhn, and J. Diaz-Buxo Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomysitis-polymyositis J Rheumatology 14 1987 1045 1047
21. T. Kotani, S. Makino, T. Takeuchi, M. Kagitani, T. Shoda, and A. Hata Early intervention with corticosteroids and cyclosporine-A and 2-hour post dose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis Journal of Rheumatology 35 2008 254 259
22. I. Koboyashi, M. Yamada, Y. Takahashi, N. Kawamura, M. Okano, Y. Sakiyama, and K. Kobayashi Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporine A Rheumatology 43 2003 371 374
23. H.D. Tezelaar, R.W. Viggiano, J. Pickersgill, and T.V. Colby Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis correlated with histology findings American Review of Respiratory Disease 141 3 1990 727 733
24. T. Yoshida, H. Koga, F. Saitoh, M. Sakamoto, M. Harada, and H. Yoshida Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis Internal Medicine 38 1999 733 738
25. T. Shinohara, T. Hidaka, Y. Matsuki, T. Ishizuka, M. Takamizawa, and M. Kawakami Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide treatment Internal Medicine 36 1997 519 523
26. H. Kameda, H. Nagasawa, H. Ogawa, N. Sekiguchi, H. Takei, and M. Tokuhira Combination treatment with corticosteroids, cyclosporine A and intravenous pulse of cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis Journal of Rheumatology 32 2005 1719 1726
27. F. Tanaka, T. Origuchi, K. Migita, M. Tominaga, A. Kawakami, Y. Kawabe, and K. Eguchi Successful combined therapy of cyclophosphamide for acute exacerbated interstitial pneumonia associated with dermatomyositis Internal Medicine 39 5 2000 428 430
28. Y. Yamasaki, H. Yamada, M. Yamasaki, M. Ohkubo, K. Azuma, and S. Matsuoka Intravenous cyclophosphamide treatment for progressive interstitial pneumonia in patients with polymyositis-dermatomyositis Rheumatology 46 2007 124 130
29. C.C. Mok, C.H. To, and M.L. Szeto Successful treatment of dermatomyositis related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine Scandinavian Journal of Rheumatology 32 2003 181 183
30. J.J. Swigris, A.L. Olson, A. Fisher, D.A. Lynch, G.P. Cosgrove, and S.K. Frankel Mycophenolate is safe, well tolerated and preserves lung function in patients with connective tissue disease-related interstitial lung disease Chest 130 2006 30 36
31. P.A. Morgannoth, M.E. Kreider, and V.P. Werth Mycophenolate mofetil for interstitial lung disease in dermatomyositis Arthritis Care & Research 62 10 2010 1496 1501
32. C.V. Oddis, F.C. Sciurba, K.A. Elmagd, and T.E. Starzi Tacrolimus in refractory polymyositis with interstitial lung disease The Lancet 353 1999 1762
33. K. Takada, K. Nagasaka, and N. Miyasaka Therapeutic approach with T-cell-specific immunosuppesants Autoimmunity 38 5 2005 383 392
34. S. Ochi, K. Nanki, K. Takada, F. Suzuki, Y. Komano, T. Kubota, and N. Miyasaka Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis-dermatomyositis Clinical and Experimental Rheumatology 23 2005 707 710
35. U. Lange, M. Piegsa, U. Muller-Ladner, and J. Strunk Anti-Jo1 positive polymyositis. Successful therapy with leflunomide Autoimmunity 39 3 2006 261 264
36. Y. Suzuki, H. Hayakawa, S. Miwa, M. Shirai, M. Fujii, H. Gemma, T. Suda, and K. Chida Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis and dermatomyositis Lung 187 2009 201 206
37. M. Sem, O. Molberg, M.B. Lund, and J.T. Gran Rituximab treatment of the anti-synthetase syndrome. A retrospective case series Rheumatology 48 2009 968 971